Please use this identifier to cite or link to this item:
|Title:||Rare cause of pulmonary hypertension - pulmonary tumour thrombotic microangiopathy.||Austin Authors:||O'Brien, Joseph M;Jones, Nicholas ;Horrigan, Mark ;Al-Kaisey, Ahmed M||Affiliation:||Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia||Issue Date:||9-Aug-2019||metadata.dc.date:||2019-08-09||Publication information:||BMJ Case Reports 2019; 12(8): e225756||Abstract:||Pulmonary tumour thrombotic microangiopathy (PTTA) is a rare but lethal cause of pulmonary hypertension (PHT). Its underlying mechanism is believed to be fibrocellular intimal proliferation and microthrombosis. It has been reported in association with gastric adenocarcinoma and breast, pancreatic and lung cancers. The diagnosis is often made on postmortem examination due to the absence of diagnostic criteria and its rare occurrence. We describe the case of a middle-aged man who presented with rapidly progressive PHT. He deteriorated into multiorgan failure despite aggressive medical therapy and died 4 weeks after his initial presentation. A postmortem examination confirmed the diagnosis of PTTA in addition to the finding of signet cell gastric adenocarcinoma. This case highlights the lethal nature of this rare condition, the ongoing challenges in making an antemortem diagnosis, and the importance of postmortem examination in determining the cause of death to provide closure for both, the treating physician and the family.||URI:||http://ahro.austin.org.au/austinjspui/handle/1/21599||DOI:||10.1136/bcr-2018-225756||ORCID:||0000-0001-5174-1034
|PubMed URL:||31401584||Type:||Journal Article||Subjects:||cancer - see oncology
|Appears in Collections:||Journal articles|
Show full item record
checked on Apr 16, 2021
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.